Suraksha Diagnostic Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Suraksha Diagnostic reported FY26 revenue from operations of INR3104.1 million, up 23.1% year-on-year, with blended EBITDA margin of 31.73% and PAT of INR314 million. Management said the year included expansion into 68 centers with new hub and spoke launches, alongside investments in genomics, molecular diagnostics and MRI technology. For FY27, management outlined plans to add hubs and spokes in West Bengal and expand into Bihar, Tripura and Jharkhand, while flagging near-term margin pressure from new center ramp-up costs.